Germinal centres seen through the mathematical eye: B-cell models on the catwalk

2009 ◽  
Vol 30 (4) ◽  
pp. 157-164 ◽  
Author(s):  
Michael Meyer-Hermann ◽  
Marc Thilo Figge ◽  
Kai-Michael Toellner
Keyword(s):  
B Cell ◽  
Nature ◽  
2020 ◽  
Vol 588 (7837) ◽  
pp. 321-326
Author(s):  
Carla R. Nowosad ◽  
Luka Mesin ◽  
Tiago B. R. Castro ◽  
Christopher Wichmann ◽  
Gregory P. Donaldson ◽  
...  

1980 ◽  
Vol 34 (1) ◽  
pp. 43-52 ◽  
Author(s):  
Dieuwertje Heijden ◽  
O. Nieweg ◽  
B. Rijkmans ◽  
Rita Stikker ◽  
Davine Opstelten ◽  
...  
Keyword(s):  
B Cell ◽  

1981 ◽  
Vol 219 (2) ◽  
pp. 281-289 ◽  
Author(s):  
Nicolette A. Gastkemper ◽  
Auk S. Wubbena ◽  
Felix J. H. Gimbrère ◽  
Alexander de Graaff ◽  
Paul Nieuwenhuis
Keyword(s):  
B Cell ◽  

2011 ◽  
Vol 71 ◽  
pp. e191
Author(s):  
Eiko Minakawa ◽  
Satoshi Horimoto ◽  
Kouji Hirota ◽  
Shunichi Takeda ◽  
Ryosuke Takahashi

PLoS ONE ◽  
2012 ◽  
Vol 7 (11) ◽  
pp. e49715 ◽  
Author(s):  
Agapitos Patakas ◽  
Robert A. Benson ◽  
David R. Withers ◽  
Paola Conigliaro ◽  
Iain B. McInnes ◽  
...  

PLoS ONE ◽  
2020 ◽  
Vol 15 (11) ◽  
pp. e0242177
Author(s):  
Miguel Thomos ◽  
Patrick Wurzel ◽  
Sonja Scharf ◽  
Ina Koch ◽  
Martin-Leo Hansmann

This study deals with 3D laser investigation on the border between the human lymph node T-zone and germinal centre. Only a few T-cells specific for antigen selected B-cells are allowed to enter germinal centres. This selection process is guided by sinus structures, chemokine gradients and inherent motility of the lymphoid cells. We measured gaps and wall-like structures manually, using IMARIS, a 3D image software for analysis and interpretation of microscopy datasets. In this paper, we describe alpha-actin positive and semipermeable walls and wall-like structures that may hinder T-cells and other cell types from entering germinal centres. Some clearly defined holes or gaps probably regulate lymphoid traffic between T- and B-cell areas. In lymphadenitis, the morphology of this border structure is clearly defined. However, in case of malignant lymphoma, the wall-like structure is disrupted. This has been demonstrated exemplarily in case of angioimmunoblastic T-cell lymphoma. We revealed significant differences of lengths of the wall-like structures in angioimmunoblastic T-cell lymphoma in comparison with wall-like structures in reactive tissue slices. The alterations of morphological structures lead to abnormal and less controlled T- and B-cell distributions probably preventing the immune defence against tumour cells and infectious agents by dysregulating immune homeostasis.


Rheumatology ◽  
2019 ◽  
Vol 59 (1) ◽  
pp. 165-170 ◽  
Author(s):  
Serena Colafrancesco ◽  
Roberta Priori ◽  
Charlotte G Smith ◽  
Antonina Minniti ◽  
Valentina Iannizzotto ◽  
...  

Abstract Objectives SS is an autoimmune condition characterized by systemic B-cell activation, autoantibody production and ectopic germinal centres’ formation within the salivary gland (SG). The extent of SG infiltrate has been proposed as a biomarker of disease severity. Plasma levels of CXCL13 correlate with germinal centres’ activity in animal models and disease severity in SS, suggesting its potential use as a surrogate serum marker to monitor local B-cell activation. The aim of this study was to evaluate the potential role of CXCL13 as a biomarker of SG pathology in two independent SS cohorts. Methods 109 patients with SS were recruited at Sapienza University of Rome (Italy) (n = 60), or at Queen Elizabeth Hospital in Birmingham and Barts Health NHS Trust in London (n = 49). Both sera and matched minor SG biopsy were available. Sicca (n = 57) and healthy subjects’ (n = 19) sera were used as control. Results CXCL13 serum level was higher in SS patients compared with controls. Correlations between its serum levels and a series of histomorphological parameters, including size of the aggregates and the presence germinal centres', were observed. Conclusion Our data foster the use of CXCL13 to monitor the extent of local pathology in SS and its validation in longitudinal clinical studies.


Immunology ◽  
2019 ◽  
Vol 157 (1) ◽  
pp. 86-91
Author(s):  
Richard K. Tennant ◽  
Barbara Holzer ◽  
John Love ◽  
Elma Tchilian ◽  
Harry N. White

Sign in / Sign up

Export Citation Format

Share Document